SCHEMBL18156327

SCHEMBL18156327

CNc1ccc(-c2cc3ccccc3c(=O)[nH]2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 6/20 0.60
▸ CDC25B P30305 6/20 0.50
▸ KDM4E B2RXH2 5/20 0.50
▸ SAE1 Q9UBE0 4/20 0.50
▸ UBA2 Q9UBT2 4/20 0.50
▸ GAA P10253 3/20 0.50
▸ UBE2I P63279 2/20 0.50
▸ ALDH1A1 P00352 4/20 0.48
▸ HPGD P15428 4/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ MAPT P10636 3/20 0.48
▸ THRB P10828 3/20 0.48
▸ APAF1 O14727 3/20 0.48
▸ CASP3 P42574 3/20 0.48
▸ SENP8 Q96LD8 3/20 0.48
▸ SENP7 Q9BQF6 3/20 0.48
▸ SENP6 Q9GZR1 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30161077 0.83 TNKS (0.65) TNKSCDC25BKDM4ESAE1UBA2
SCHEMBL28924699 0.83 TNKS (0.65) TNKSCDC25BKDM4ESAE1UBA2
SCHEMBL828493 0.82 TNKS (0.63) TNKSCDC25BKDM4ESAE1UBA2
SCHEMBL29639160 0.82 TNKS (0.63) TNKSCDC25BKDM4ESAE1UBA2
SCHEMBL311943 0.80 TNKS (0.61) TNKSCDC25BKDM4ESAE1UBA2
SCHEMBL28624953 0.80 PARP1 (0.61) TNKSCDC25BKDM4ESAE1UBA2
SCHEMBL28629565 0.80 TNKS (0.61) TNKSCDC25BKDM4ESAE1UBA2
SCHEMBL4774571 0.80 TNKS (0.61) TNKSCDC25BKDM4ESAE1UBA2
SCHEMBL30160913 0.80 PARP1 (0.61) TNKSCDC25BKDM4ESAE1UBA2
SCHEMBL16578791 0.80 TNKS (0.61) TNKSCDC25BKDM4ESAE1UBA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2822656-B1 3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE CANCER RES INST ROYAL (GB) 2016-10-19 — — EP disclosed
Send feedback